Evidence map›Paper›PMID 30569575›Full record

ArticleAngewandte Chemie (International ed. in English)2019

Non-Hydrolytic β-Lactam Antibiotic Fragmentation by l,d-Transpeptidases and Serine β-Lactamase Cysteine Variants.

Christopher T Lohans, H T Henry Chan, Tika R Malla, Kiran Kumar, Jos J A G Kamps, Darius J B McArdle, Emma van Groesen, Mariska de Munnik, Catherine L Tooke, James Spencer and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Competing off-loading mechanisms of meropenem from an l,d-transpeptidase reduce antibiotic effectiveness.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  12. Article
  13. Amoxicillin Haptenation ofFrontiers in pharmacology · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Targeting the Mycobacterium tuberculosis transpeptidase LdtChemical communications (Cambridge, England) · 2019
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Christopher T LohansDepartment of Chemistry, University of Oxford, Oxford, OX1 3TA, UK.ORCID 0000-0003-1094-0349
H T Henry ChanDepartment of Chemistry, University of Oxford, Oxford, OX1 3TA, UK.
Tika R MallaDepartment of Chemistry, University of Oxford, Oxford, OX1 3TA, UK.
Kiran KumarDepartment of Chemistry, University of Oxford, Oxford, OX1 3TA, UK.ORCID 0000-0002-5615-6237
Jos J A G KampsDepartment of Chemistry, University of Oxford, Oxford, OX1 3TA, UK.ORCID 0000-0001-8646-1796
Darius J B McArdleDepartment of Chemistry, University of Oxford, Oxford, OX1 3TA, UK.
Emma van GroesenDepartment of Chemistry, University of Oxford, Oxford, OX1 3TA, UK.ORCID 0000-0003-2991-8256
Mariska de MunnikDepartment of Chemistry, University of Oxford, Oxford, OX1 3TA, UK.
Catherine L TookeSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, BS8 1TD, UK.ORCID 0000-0003-2180-3235
James SpencerSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, BS8 1TD, UK.
Robert S PatonDepartment of Chemistry, University of Oxford, Oxford, OX1 3TA, UK.ORCID 0000-0002-0104-4166
Jürgen BremDepartment of Chemistry, University of Oxford, Oxford, OX1 3TA, UK.ORCID 0000-0002-0137-3226
Christopher J SchofieldDepartment of Chemistry, University of Oxford, Oxford, OX1 3TA, UK.ORCID 0000-0002-0290-6565
University of Oxford · GBUniversity of Bristol · GB

Funding

Biotechnology and Biological Sciences Research Council BB/M011224/1Engineering and Physical Sciences Research Council BB/L009846/1Medical Research Council MC_PC_14103Medical Research Council MC_PC_16092Medical Research Council MR/L007665/1Medical Research Council MR/N002679/1Medical Research Council MR/P007503/1Tres Cantos Open Lab Foundation Project TC 241Wellcome TrustWellcome Trust 106244/Z/14/Z
6 · The paper itself

Abstract

Enzymes often use nucleophilic serine, threonine, and cysteine residues to achieve the same type of reaction; the underlying reasons for this are not understood. While bacterial d,d-transpeptidases (penicillin-binding proteins) employ a nucleophilic serine, l,d-transpeptidases use a nucleophilic cysteine. The covalent complexes formed by l,d-transpeptidases with some β-lactam antibiotics undergo non-hydrolytic fragmentation. This is not usually observed for penicillin-binding proteins, or for the related serine β-lactamases. Replacement of the nucleophilic serine of serine β-lactamases with cysteine yields enzymes which fragment β-lactams via a similar mechanism as the l,d-transpeptidases, implying the different reaction outcomes are principally due to the formation of thioester versus ester intermediates. The results highlight fundamental differences in the reactivity of nucleophilic serine and cysteine enzymes, and imply new possibilities for the inhibition of nucleophilic enzymes.

Indexed as

Anti-Bacterial Agentsbeta-Lactamasesbeta-LactamsCysteineMolecular ConformationPeptidyl TransferasesAnti-Bacterial Agentsbeta-Lactamasesbeta-LactamsCysteinePeptidyl Transferasesantibiotic resistancefragmentationhydrolasestranspeptidasesβ-lactamases

Identifiers

PMID30569575
PMCPMC6391942
OpenAlexW2906206077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.